4.3 Article

Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery

Journal

JOURNAL OF CARDIOVASCULAR MEDICINE
Volume 9, Issue 11, Pages 1098-1103

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.2459/JCM.0b013e32830a6daf

Keywords

coronary artery bypass graft; cardioplegia; cardiopulmonary bypass; myocardial protection; surgery

Ask authors/readers for more resources

Objectives Coronary artery bypass graft surgery may result in perioperative myocardial injury during cardioplegic arrest. Angiotensin-converting enzyme (ACE) inhibitors protect the myocardium from ischemia in several clinical conditions, but no previous study has attempted to evaluate the impact of preoperative ACE inhibitor therapy on myocardial protection in patients undergoing coronary artery bypass graft surgery. Methods A propensity score-based analysis of 481 patients undergoing isolated on-pump coronary artery bypass graft surgery was carried out, among which 245 patients received preoperative ACE inhibitors and 236 patients did not. Perioperative myocardial injury was assessed by ischemia marker cardiac troponin I (cTnI). Results Preoperative cTnI concentration was similar for patients receiving ACE inhibitors and those who did not (0.1 ng/ml (0.06-0.19) versus 0.1 ng/ml (0.06-0.19); P = 0.3]. Postoperative cTnI peak concentration was lower in patients receiving preoperative ACE inhibitors [1.6 ng/ml (1.05-3.4) versus 2.4ng/ml (1.13-6.10); P = 0.0006]. After adjusting for propensity score and covariates, preoperative ACE inhibitors were found to decrease postoperative cTnI peak concentration (beta = -0.12; P = 0.004). Other independent predictors of postoperative cTnI peak concentration were female gender, emergency surgery, number of distal anastomoses and aortic cross clamp time. Overall, operative mortality rate was 16/481 (3.3%). Patients receiving preoperative ACE inhibitors had a lower rate of postoperative myocardial infarction (2.0 versus 4.2%; P = 0.25) and low cardiac output syndrome (3.6 versus 6.3%; P = 0.24). Conclusion ACE inhibitors prior to surgery confer added myocardial protection during surgical revascularization. Prospective, randomized clinical trials will be necessary to better define the role of ACE inhibitors in improving outcomes when they are prescribed prior to coronary artery bypass graft surgery. J Cardiovasc Med 9:1098-1103 (C) 2008 Italian Federation of Cardiology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Cardiac & Cardiovascular Systems

Commentary: Do or do not. There is no try: Which role for minimally invasive direct coronary artery bypass?

Arnaldo Dimagli, Umberto Benedetto

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2023)

Article Cardiac & Cardiovascular Systems

Association between sternal wound complications and 10-year mortality following coronary artery bypass grafting

Mario Gaudino, Katia Audisio, Mohamed Rahouma, N. Bryce Robinson, Giovanni J. Soletti, Gianmarco Cancelli, Ruth M. Masterson Creber, Alastair Gray, Belinda Lees, Stephen Gerry, Umberto Benedetto, Marcus Flather, David P. Taggart, Arterial Revascularization Trial Arterial Revascularizat Trial Investigators

Summary: This study evaluated the association between sternal wound complications (SWC) and long-term mortality in the Arterial Revascularization Trial. The results showed that postoperative SWC was significantly associated with long-term mortality and increased rates of major adverse cardiovascular events.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2023)

Review Cardiac & Cardiovascular Systems

Tricuspid regurgitation management: a systematic review of clinical practice guidelines and recommendations

Fabrizio Ricci, Gabriella Bufano, Victor Galusko, Baskar Sekar, Umberto Benedetto, Wael Awad, Michele di Mauro, Sabina Gallina, Adrian Ionescu, Luigi Badano, Mohammed Y. Khanji

Summary: Tricuspid regurgitation is a prevalent condition with varying clinical guidelines for diagnosis and management. While there are areas of consensus, discrepancies and lack of evidence exist in certain aspects.

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2022)

Review Cardiac & Cardiovascular Systems

Standardized Aortic Valve Neocuspidization for Treatment of Aortic Valve Diseases

Andrea Amabile, Markus Krane, Keith Dufendach, Christopher W. Baird, Nikhil Ganjoo, Friedrich S. Eckstein, Alberto Albertini, Peter J. Gruber, Mubashir A. Mumtaz, Emile A. Bacha, Umberto Benedetto, Joanna Chikwe, Arnar Geirsson, Johannes Holfeld, Yasunori Iida, Rudiger Lange, Victor O. Morell, Danny Chu

Summary: AVNeo is a reliable and standardized alternative to aortic valve replacement, with excellent short to midterm outcomes demonstrating the safety and durability of the procedure. Long-term outcomes and clinical trial data are needed to determine the most suitable patients for this surgery.

ANNALS OF THORACIC SURGERY (2022)

Review Cardiac & Cardiovascular Systems

Network meta-analysis comparing blood cardioplegia, Del Nido cardioplegia and custodiol cardioplegia in minimally invasive cardiac surgery

Jeremy Chan, Shwe Oo, Salman Butt, Umberto Benedetto, Massimo Caputo, Gianni D. Angelini, Hunaid A. Vohra

Summary: This study indicates that there is no difference in clinical outcomes between blood and crystalloid cardioplegia in adult minimally invasive cardiac surgery. The choice of cardioplegia in minimally invasive cardiac surgery remains dependent on the surgeon's decision and preference.

PERFUSION-UK (2023)

Article Cardiac & Cardiovascular Systems

Impact of Preoperative Atrial Fibrillation on In- Hospital Outcomes of Coronary Artery Bypass Grafting

Daniel Paul Fudulu, Arnaldo Dimagli, Shubhra Sinha, James Ackah, Pradeep Narayan, Jeremy Chan, Marco Gemelli, Tim Dong, Umberto Benedetto, Gianni Davide Angelini

SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY (2023)

Article Surgery

What Are Patients Told About Innovative Surgical Procedures? A Qualitative Synthesis of 7 Case Studies in the United Kingdom

Daisy A. Elliott, Cynthia A. Ochieng, Jesmond Zahra, Angus G. K. G. McNair, Barry G. Main, Anni S. Skilton, Natalie S. Blencowe, Sian Cousins, Sangeetha Paramasivan, Christin L. Hoffmann, Jenny L. M. Donovan, Jane M. Blazeby, Lotus Clin Innovator Collaborators

Summary: This study investigated how information about innovative surgical procedures is communicated to patients. Through qualitative research on seven case studies in hospitals across the United Kingdom, interviews were conducted with clinician innovators, preoperative consultations were recorded, and postoperative interviews were conducted with patients. The study found inconsistencies between clinicians' intentions to inform patients about uncertain outcomes and their actual discussions with patients. Many patients were unaware of the unknown risks associated with the procedure.

ANNALS OF SURGERY (2023)

Article Cardiac & Cardiovascular Systems

Incidence and Impact of a Single-Unit Red Blood Cell Transfusion: Analysis of The Society of Thoracic Surgeons Database 2010-2019

Natalia Ivascu Girardi, Melissa M. Cushing, Lisbeth A. Evered, Umberto Benedetto, Thomas A. Schwann, Paul Kurlansky, Robert H. Habib, Mario F. L. Gaudino

Summary: Isolated single-unit red blood cell transfusions are common in cardiac surgery patients and are associated with higher morbidity.

ANNALS OF THORACIC SURGERY (2023)

Editorial Material Cardiac & Cardiovascular Systems

Omnia munda mundis ('to the pure, all things are pure')

Mario Gaudino, John Alexander, Umberto Benedetto, Andreas Boening, Arnaldo Dimagli, Stephen Fremes, Joanna Chikwe, Leonard Girardi, David Hare, Paul Kurlansky, Andre Lamy, Katia Audisio, Antonino Di Franco, P. J. Devereaux, Anno Diegeler, Marcus Flather, Jennifer S. Lawton, Derrick Y. Tam, Wilko Reents, Mohamed Rahouma

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2023)

Article Health Care Sciences & Services

Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies

Jessica Harris, Koen B. Pouwels, Thomas Johnson, Jonathan Sterne, Christalla Pithara, Kalaivani Mahadevan, Barney Reeves, Umberto Benedetto, Yoon Loke, Daniel Lasserson, Brett Doble, Noreen Hopewell-Kelly, Sabi Redwood, Sarah Wordsworth, Andrew Mumford, Chris Rogers, Maria Pufulete

Summary: This study quantified the bleeding risk among patients undergoing different antiplatelet and triple therapy regimens for percutaneous coronary intervention or coronary artery bypass grafting, as well as conservatively managed acute coronary syndrome. The results suggest that more potent dual antiplatelet therapy may increase the risk of bleeding without reducing the incidence of major adverse cardiovascular events.

HEALTH TECHNOLOGY ASSESSMENT (2023)

Article Medicine, General & Internal

Outcome monitoring and risk stratification after cardiac procedure in neonates, infants, children and young adults born with congenital heart disease: protocol for a multicentre prospective cohort study (Children OMACp)

Mai Baquedano, Samantha E. de Jesus, Filippo Rapetto, Gavin J. Murphy, Gianni Angelini, Umberto Benedetto, Patricia Caldas, Prashant K. Srivastava, Orhan Uzun, Karen Luyt, Cecilia Gonzalez Corcia, Demetris Taliotis, Serban Stoica, Deborah A. Lawlor, Andrew R. Bamber, Alison Perry, Katie L. Skeffington, Ikenna Omeje, John Pappachan, Andrew D. Mumford, Richard J. M. Coward, Damien Kenny, Massimo Caputo

Summary: This study aims to establish a prospective cohort of patients with congenital heart disease (CHD) undergoing cardiac procedures. It will collect clinical data, biological samples, and participant questionnaires to investigate risk factors, predictors, and the effects of surgery on outcomes.

BMJ OPEN (2023)

Article Health Care Sciences & Services

Cardiac surgery risk prediction using ensemble machine learning to incorporate legacy risk scores: A benchmarking study

Tim Dong, Shubhra Sinha, Ben Zhai, Daniel P. Fudulu, Jeremy Chan, Pradeep Narayan, Andy Judge, Massimo Caputo, Arnaldo Dimagli, Umberto Benedetto, Gianni D. Angelini

Summary: This study combines EuroSCORE I and EuroSCORE II data using ensemble learning methods to predict cardiac surgery risk. The results show that both homogeneous and heterogeneous machine learning ensembles perform better than dynamic model averaging ensembles.

DIGITAL HEALTH (2023)

Article Cardiac & Cardiovascular Systems

Comparison of machine learning techniques in prediction of mortality following cardiac surgery: analysis of over 220 000 patients from a large national database

Shubhra Sinha, Tim Dong, Arnaldo Dimagli, Hunaid A. Vohra, Chris Holmes, Umberto Benedetto, Gianni D. Angelini

Summary: This study systematically compared the in-hospital mortality risk prediction post-cardiac surgery using different approaches, including the EuroSCORE II, logistic regression, and various machine learning techniques. The results showed that machine learning techniques, such as XGBoost and random forest, had some statistical improvements over traditional models. However, the clinical impact of these improvements is currently modest.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2023)

Article Mathematical & Computational Biology

Tailored Bayes: a risk modeling framework under unequal misclassification costs

Solon Karapanagiotis, Umberto Benedetto, Sach Mukherjee, Paul D. W. Kirk, Paul J. Newcombe

Summary: Risk prediction models are crucial in healthcare, but the assumption that the costs of different classification errors are equal may not be valid in many healthcare applications. Tailored Bayes (TB) is introduced as a Bayesian framework to optimize predictive performance with respect to unbalanced misclassification costs, showing improvement over standard methods in simulation studies and real-world applications.

BIOSTATISTICS (2022)

Article Cardiac & Cardiovascular Systems

Cost-effectiveness of bilateral vs. single internal thoracic artery grafts at 10 years

Matthew Little, Alastair M. Gray, Douglas G. Altman, Umberto Benedetto, Marcus Flather, Stephen Gerry, Belinda Lees, Jacqueline Murphy, Mario Gaudino, David P. Taggart

Summary: Using bilateral internal thoracic arteries (BITAs) for coronary artery bypass grafting (CABG) has been suggested to improve survival compared to CABG using single internal thoracic arteries (SITAs) for patients with advanced coronary artery disease. This study found that while BITA grafting has significantly higher costs, it offers similar quality-adjusted survival at 10 years compared to SITA grafting. Extrapolation suggests that this cost-effectiveness advantage of BITA grafting could potentially change over a patient's lifetime.

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2022)

No Data Available